Agrx News Today

Agile Therapeutics (NASDAQ:AGRX – Get Free Report) and Indivior (NASDAQ:INDV – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 10.9% of Agile Therapeutics shares […]

Agile Therapeutics (NASDAQ:AGRX – Get Free Report) and Indivior (NASDAQ:INDV – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk. Profitability This table compares Agile Therapeutics and Indivior’s net […]

Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Free Report) shares crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $2.03 and traded as high as $2.03. Agile Therapeutics shares last traded at $1.88, with a volume of 74,942 shares traded. Wall Street Analyst Weigh […]

StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group raised Agile Therapeutics from a hold rating to a buy rating and set a $5.00 target price on the […]

StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a research report released on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group upgraded Agile Therapeutics from a hold rating to a buy rating and set a $5.00 price target for the company […]

StockNews.com started coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a research report report published on Sunday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group raised shares of Agile Therapeutics from a hold rating to a buy rating and set a $5.00 target price on […]

StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a report released on Friday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group raised shares of Agile Therapeutics from a hold rating to a buy rating and set a $5.00 price target on the […]

Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Free Report) was the target of a large decrease in short interest in October. As of October 15th, there was short interest totalling 4,400 shares, a decrease of 76.5% from the September 30th total of 18,700 shares. Currently, 0.2% of the company’s shares are sold short. Based on an […]

Maxim Group upgraded shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday, Marketbeat.com reports. They currently have $5.00 price target on the specialty pharmaceutical company’s stock. Several other research analysts have also commented on the company. HC Wainwright reiterated […]

AGRX | Complete Agile Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.